XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
Holding XTLB?
Track your performance easily

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) Financial Statements

95 Followers

XTL Biopharmaceuticals Ltd. Sponsored ADR Financial Overview

XTL Biopharmaceuticals Ltd. Sponsored ADR's market cap is currently ―. The company's EPS TTM is $-0.069; its P/E ratio is -35.94; XTL Biopharmaceuticals Ltd. Sponsored ADR is scheduled to report earnings on December 5, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT--$ -896.00K$ -274.00K$ -249.00K
EBITDA--$ -896.00K$ -274.00K$ -249.00K
Net Income Common Stockholders--$ -821.00K$ -285.00K$ 506.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.01M$ 2.09M$ 4.39M$ 5.16M$ 2.79M
Total Assets$ 2.43M$ 4.19M$ 4.90M$ 5.76M$ 6.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.01M$ -2.09M$ -4.39M$ -5.16M$ -2.79M
Total Liabilities$ 206.00K$ 14.33M$ 153.00K$ 194.00K$ 777.00K
Stockholders Equity$ 2.22M$ -10.14M$ 4.74M$ 5.56M$ 5.84M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

XTL Biopharmaceuticals Ltd. Sponsored ADR Earnings and Revenue History

XTL Biopharmaceuticals Ltd. Sponsored ADR Debt to Assets

XTL Biopharmaceuticals Ltd. Sponsored ADR Cash Flow

XTL Biopharmaceuticals Ltd. Sponsored ADR Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis